PFBT
KYMR icon

Parkside Financial Bank & Trust’s Kymera Therapeutics KYMR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.66K Hold
68
– – ﹤0.01% 1782
2025
Q4 		$5.29K Hold
68
– – ﹤0.01% 1781
2025
Q3 		$3.85K Buy
68
+12
+21% +$541 ﹤0.01% 1809
2025
Q2 		$2.44K Buy
+56
New +$1.93K ﹤0.01% 1931

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Parkside Financial Bank & Trust's KYMR Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Kymera Therapeutics (KYMR) position steady in Q1 2026 at 68 shares worth $5.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Parkside Financial Bank & Trust first reported a position in KYMR in Q2 2025 and has held it in 4 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Parkside Financial Bank & Trust held 68 shares of Kymera Therapeutics worth $5.66K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Kymera Therapeutics share count unchanged in Q1 2026.
  • Kymera Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1782 holding.
  • Parkside Financial Bank & Trust first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.